Seven Eight Capital, LP Inogen Inc Transaction History

Seven Eight Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$32.63 - $67.59 $593,800 - $1.23 Million	-18,198 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$45.95 - $76.15 $652,490 - $1.08 Million	-14,200 Reduced 43.83%	18,198 $1.24 Million
Q3 2019 Nov 14, 2019	BUY	$41.82 - $66.71 $468,384 - $747,151	11,200 Added 52.84%	32,398 $1.55 Million
Q2 2019 Aug 12, 2019	SELL	$63.19 - $95.15 $1.27 Million - $1.91 Million	-20,102 Reduced 48.67%	21,198 $1.42 Million
Q1 2019 May 15, 2019	BUY	$90.12 - $152.23 $3.72 Million - $6.29 Million	41,300 New	41,300 $3.94 Million

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $220M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.